Related Experiment Video
Updated: Jun 10, 2026

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
Published on: December 13, 2024
Common and emerging fungal pulmonary infections
Li Yang Hsu1, Esther Shu-Ting Ng, Liang Piu Koh
1Department of Medicine, National University Health System, Singapore 119074, Singapore. liyang_hsu@yahoo.com
Abstract:
Fungal pulmonary infections are becoming more prevalent as a consequence of the rising prevalence of immunocompromised patients. Besides ubiquitous opportunistic fungi such as Aspergillus spp and geographically delimited mycoses, fungi that were previously thought to be of uncertain pathogenicity, such as hyaline and dematiaceous molds, are increasingly being diagnosed as the causes of invasive disease in profoundly immunosuppressed hosts. Overall progress in the clinical management of fungal pulmonary infections has been slow compared with other areas of infectious diseases. However, recent encouraging advances in fungal diagnostics and therapeutics have resulted in improved clinical outcomes, particularly in vulnerable patient populations such as solid organ or allogeneic hematopoietic stem cell transplant recipients. This article provides an overview of endemic mycoses and other emerging fungal pulmonary infections. Recent developments in terms of the diagnosis and clinical management of these infections are also discussed.
Insights
Fungal pulmonary infections are rising in immunocompromised individuals. Advances in diagnostics and therapeutics are improving outcomes for vulnerable patients, including transplant recipients.
Area of Science:
- Infectious Diseases
- Mycology
- Pulmonology
Background:
- Fungal pulmonary infections are increasingly prevalent due to a rise in immunocompromised patients.
- Previously low-pathogenicity fungi like molds are now causing invasive disease in severely immunocompromised hosts.
- Progress in managing these infections has lagged behind other infectious diseases.
Purpose of the Study:
- To provide an overview of endemic and emerging fungal pulmonary infections.
- To discuss recent advancements in the diagnosis and clinical management of these infections.
Main Methods:
- Literature review of endemic mycoses and emerging fungal pulmonary infections.
- Analysis of recent developments in diagnostic tools and therapeutic strategies.
- Focus on clinical management, particularly in vulnerable populations.
Main Results:
- Fungal infections are a growing concern, especially in immunocompromised individuals.
- Emerging fungal pathogens, including molds, are increasingly implicated in invasive diseases.
- Recent diagnostic and therapeutic advances show promise for improved patient outcomes.
Conclusions:
- Despite slow overall progress, new diagnostic and therapeutic approaches are enhancing the management of fungal pulmonary infections.
- Improved clinical outcomes are particularly noted in high-risk groups like solid organ and hematopoietic stem cell transplant recipients.
- Continued research and development are crucial for addressing the challenges posed by these infections.
Related Concept Videos
Cryptococcal Meningitis
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Fungal Phylum Ascomycota
